These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26093506)

  • 1. Association of the anti-tuberculosis drug rifampicin with a PAMAM dendrimer.
    Bellini RG; Guimarães AP; Pacheco MA; Dias DM; Furtado VR; de Alencastro RB; Horta BA
    J Mol Graph Model; 2015 Jul; 60():34-42. PubMed ID: 26093506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding free energy calculations using MMPB/GBSA approaches for PAMAM-G4-drug complexes at neutral, basic and acid pH conditions.
    Martínez-Muñoz A; Bello M; Romero-Castro A; Rodríguez-Fonseca RA; Rodrigues J; Sánchez-Espinosa VA; Correa-Basurto J
    J Mol Graph Model; 2017 Sep; 76():330-341. PubMed ID: 28759825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atomic level insights into realistic molecular models of dendrimer-drug complexes through MD simulations.
    Jain V; Maiti PK; Bharatam PV
    J Chem Phys; 2016 Sep; 145(12):124902. PubMed ID: 27782646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of nicotinic acid with a poly(amidoamine) dendrimer studied by molecular dynamics simulations.
    Caballero J; Poblete H; Navarro C; Alzate-Morales JH
    J Mol Graph Model; 2013 Feb; 39():71-8. PubMed ID: 23220284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics simulations of polyamidoamine dendrimers and their complexes with linear poly(ethylene oxide) at different pH conditions: static properties and hydrogen bonding.
    Tanis I; Karatasos K
    Phys Chem Chem Phys; 2009 Nov; 11(43):10017-28. PubMed ID: 19865754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA compaction by a dendrimer.
    Nandy B; Maiti PK
    J Phys Chem B; 2011 Jan; 115(2):217-30. PubMed ID: 21171620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aqueous poly(amidoamine) dendrimer G3 and G4 generations with several interior cores at pHs 5 and 7: a molecular dynamics simulation study.
    Kavyani S; Amjad-Iranagh S; Modarress H
    J Phys Chem B; 2014 Mar; 118(12):3257-66. PubMed ID: 24588382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypropyleneimine and polyamidoamine dendrimer mediated enhanced solubilization of bortezomib: Comparison and evaluation of mechanistic aspects by thermodynamics and molecular simulations.
    Chaudhary S; Gothwal A; Khan I; Srivastava S; Malik R; Gupta U
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():611-619. PubMed ID: 28024628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAMAM dendrimer-drug interactions: effect of pH on the binding and release pattern.
    Maingi V; Kumar MV; Maiti PK
    J Phys Chem B; 2012 Apr; 116(14):4370-6. PubMed ID: 22420638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro enzymatic stability of dendritic peptides.
    Yang H; Lopina ST
    J Biomed Mater Res A; 2006 Feb; 76(2):398-407. PubMed ID: 16270346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computationally efficient methodology for atomic-level characterization of dendrimer-drug complexes: a comparison of amine- and acetyl-terminated PAMAM.
    Vergara-Jaque A; Comer J; Monsalve L; González-Nilo FD; Sandoval C
    J Phys Chem B; 2013 Jun; 117(22):6801-13. PubMed ID: 23642174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pH on PAMAM dendrimer-siRNA complexation: endosomal considerations as determined by molecular dynamics simulation.
    Ouyang D; Zhang H; Parekh HS; Smith SC
    Biophys Chem; 2011 Oct; 158(2-3):126-33. PubMed ID: 21752532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers.
    Yiyun C; Tongwen X
    Eur J Med Chem; 2005 Nov; 40(11):1188-92. PubMed ID: 16153746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulation of Rifampicin in a solid lipid nanoparticulate system to limit its degradation and interaction with Isoniazid at acidic pH.
    Singh H; Bhandari R; Kaur IP
    Int J Pharm; 2013 Mar; 446(1-2):106-11. PubMed ID: 23410991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance evaluation of PAMAM dendrimer based simvastatin formulations.
    Kulhari H; Pooja D; Prajapati SK; Chauhan AS
    Int J Pharm; 2011 Feb; 405(1-2):203-9. PubMed ID: 21145960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyamidoamine dendrimers used as solubility enhancers of ketoprofen.
    Yiyun C; Tongwen X; Rongqiang F
    Eur J Med Chem; 2005 Dec; 40(12):1390-3. PubMed ID: 16226353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(amidoamine)-based dendrimer/siRNA complexation studied by computer simulations: effects of pH and generation on dendrimer structure and siRNA binding.
    Karatasos K; Posocco P; Laurini E; Pricl S
    Macromol Biosci; 2012 Feb; 12(2):225-40. PubMed ID: 22147430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of poly(amidoamine) dendrimers as drug carriers of camptothecin based on encapsulation studies.
    Cheng Y; Li M; Xu T
    Eur J Med Chem; 2008 Aug; 43(8):1791-5. PubMed ID: 18215444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubility of nicotinic acid in polyamidoamine dendrimer solutions.
    Yiyun C; Tongwen X
    Eur J Med Chem; 2005 Dec; 40(12):1384-9. PubMed ID: 16226352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid.
    Madaan K; Lather V; Pandita D
    Drug Deliv; 2016; 23(1):254-62. PubMed ID: 24845475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.